[HTML][HTML] Osteoporosis pathogenesis and treatment: existing and emerging avenues

B Liang, G Burley, S Lin, YC Shi - Cellular & Molecular Biology Letters, 2022 - Springer
Osteoporotic fractures lead to increased disability and mortality in the elderly population.
With the rapid increase in the aging population around the globe, more effective treatments …

[HTML][HTML] The development of molecular biology of osteoporosis

Y Gao, S Patil, J Jia - International journal of molecular sciences, 2021 - mdpi.com
Osteoporosis is one of the major bone disorders that affects both women and men, and
causes bone deterioration and bone strength. Bone remodeling maintains bone mass and …

[HTML][HTML] Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism

MM Weivoda, CK Chew, DG Monroe, JN Farr… - Nature …, 2020 - nature.com
Bone remodeling consists of resorption by osteoclasts followed by formation by osteoblasts,
and osteoclasts are a source of bone formation-stimulating factors. Here we utilize …

[HTML][HTML] Bone regeneration, reconstruction and use of osteogenic cells; from basic knowledge, animal models to clinical trials

G Hutchings, L Moncrieff, C Dompe, K Janowicz… - Journal of clinical …, 2020 - mdpi.com
The deterioration of the human skeleton's capacity for self-renewal occurs naturally with age.
Osteoporosis affects millions worldwide, with current treatments including pharmaceutical …

[HTML][HTML] A review of small molecule inhibitors and functional probes of human cathepsin L

D Dana, SK Pathak - Molecules, 2020 - mdpi.com
Human cathepsin L belongs to the cathepsin family of proteolytic enzymes with primarily an
endopeptidase activity. Although its primary functions were originally thought to be only of a …

[HTML][HTML] Cathepsin K: a versatile potential biomarker and therapeutic target for various cancers

D Qian, L He, Q Zhang, W Li, D Tang, C Wu, F Yang… - Current …, 2022 - mdpi.com
Cancer, a common malignant disease, is one of the predominant causes of diseases that
lead to death. Additionally, cancer is often detected in advanced stages and cannot be …

Can cysteine protease cross-class inhibitors achieve selectivity?

L Cianni, CW Feldmann, E Gilberg… - Journal of medicinal …, 2019 - ACS Publications
Cysteine proteases are important targets for the discovery of novel therapeutics for many
human diseases. From parasitic diseases to cancer, cysteine proteases follow a common …

The osteoclast cytoskeleton–current understanding and therapeutic perspectives for osteoporosis

A Blangy, G Bompard, D Guerit, P Marie… - Journal of cell …, 2020 - journals.biologists.com
Osteoclasts are giant multinucleated myeloid cells specialized for bone resorption, which is
essential for the preservation of bone health throughout life. The activity of osteoclasts relies …

[HTML][HTML] Static magnetic field: A potential tool of controlling stem cells fates for stem cell therapy in osteoporosis

J Wang, P Shang - Progress in Biophysics and Molecular Biology, 2023 - Elsevier
Osteoporosis is a kind of bone diseases characterized by dynamic imbalance of bone
formation and bone absorption, which is prone to fracture, and seriously endangers human …

Non-flavonoid polyphenols in osteoporosis: Preclinical evidence

D Bellavia, F Caradonna, E Dimarco, V Costa… - Trends in Endocrinology …, 2021 - cell.com
The development of progressive osteopenia and osteoporosis (OP) is due to the imbalance
between bone resorption and bone formation, determining a lower bone resistance, major …